Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...
In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics ...
Zacks Investment Research on MSN22h
Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?Illumina, Inc. ILMN and Nashville Biosciences, LLC (NashBio) recently announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. The insights ...
Keith Meister’s hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback